Previous studies reported that Icaritin inhibits the growth of liver cancer cells through promoting the apoptosis of hepatoma cells by activating the caspase pathway and inhibiting the IL-6/Jak2/Stat3 signaling pathway [33, 34]. The gene discussed is JAK2; the disease is hepatocellular carcinoma.